TARS
Tarsus Pharmaceuticals, Inc.
+0.47 (+0.61%)78.11USD119K成交股數3.4B市值–本益比(近四季)5.7股價營收比+69.4%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 174M+69% | 162M+107% | 152M+215% | 119M+191% | 103M+272% | 78.3M+499% | 48.1M+2472% | 40.8M | 27.6M | 13.1M | 1.9M | 0.00 |
| 營業成本 | 12.1M | 9.4M | – | – | 6.2M | 5.2M | – | – | – | – | – | 0.00 |
| 毛利 | 162M+68% | 153M+109% | – | – | 96.4M | 73.1M | – | – | – | – | – | 0.00 |
| 毛利率 | 93.0% | 94.2% | – | – | 93.9% | 93.3% | – | – | – | – | – | – |
| 研發費用 | 31.0M | 22.4M | 18.0M | 16.3M | 15.6M | 14.4M | 12.1M | 12.3M | 12.1M | 13.3M | 12.1M | 12.5M |
| 銷售管理費用 | 151M | 136M | 131M | 109M | 103M | 85.0M | 57.9M | 58.8M | 51.6M | 43.0M | 30.3M | 20.3M |
| 營業利益 | −19.9M-10% | −6.1M-77% | −8.0M-68% | −14.5M-56% | −22.2M-41% | −26.3M-41% | −25.2M-39% | −33.3M+1% | −37.7M | −44.5M | −40.9M | −32.8M |
| 營業利益率 | -11.4% | -3.8% | -5.3% | -12.2% | -21.6% | -33.5% | -52.3% | -81.6% | -136.5% | -339.9% | -2,187.9% | – |
| 稅後淨利 | −18.6M-9% | −7.0M-72% | −8.0M-66% | −12.6M-62% | −20.3M-43% | −25.1M-40% | −23.4M-40% | −33.3M+6% | −35.7M | −42.0M | −39.1M | −31.4M |
| 淨利率 | -10.7% | -4.3% | -5.2% | -10.6% | -19.8% | -32.1% | -48.7% | -81.6% | -129.4% | -321.3% | -2,092.4% | – |
| 稀釋 EPS | -0.43-10% | -0.16-75% | -0.17-72% | -0.30-66% | -0.48-52% | -0.64-50% | -0.61-52% | -0.88-25% | -1.01 | -1.29 | -1.28 | -1.17 |
| 稀釋股數 | 43.4M | 43.0M | 41.8M | 42.6M | 42.4M | 39.3M | 38.4M | 37.8M | 35.3M | 29.4M | 30.6M | 26.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 205M | 102M | 184M | 113M | 96.6M | 176M | 176M | 181M | 194M | 225M | 227M | 107M |
| 應收帳款 | 96.0M | 100M | 85.1M | 72.6M | 58.3M | 62.4M | 29.2M | 29.5M | 29.9M | 16.6M | 5.4M | – |
| 存貨 | 4.4M | 4.6M | 4.4M | 3.8M | 3.9M | 2.7M | 2.8M | 2.2M | 4.0M | 3.1M | 15K | – |
| 總資產 | 611M | 581M | 562M | 535M | 495M | 501M | 376M | 377M | 349M | 265M | 268M | 189M |
| 有息負債 | 72.8M | 72.6M | 72.4M | 72.3M | 72.1M | 72.0M | 71.7M | 71.6M | 29.9M | 29.8M | 29.7M | 24.6M |
| 總負債 | 264M | 232M | 219M | 199M | 162M | 158M | 139M | 125M | 74.1M | 68.5M | 54.7M | 41.2M |
| 股東權益 | 347M | 349M | 343M | 335M | 333M | 342M | 237M | 252M | 275M | 197M | 214M | 148M |
| 負債比 | 43.3% | 40.0% | 38.9% | 37.3% | 32.8% | 31.6% | 36.9% | 33.1% | 21.2% | 25.8% | 20.4% | 21.8% |
| 淨現金(現金 − 有息負債) | 132M | 29.6M | 111M | 40.4M | 24.5M | 104M | 105M | 110M | 164M | 195M | 197M | 82.2M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −24.7M+19% | – | – | – | −20.7M | – | – | −37.8M | – | – | – |
| 資本支出 | – | 5.8M | – | – | – | 590K | – | – | 174K | – | – | – |
| 自由現金流 | – | −30.5M+43% | – | – | – | −21.2M | – | – | −38.0M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -18.8% | – | – | – | -27.1% | – | – | -137.5% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 451M
| Reportable | 451M | 100.0% | +146.7% |
|---|
產品／服務2025 年度 · 451M
| 產品 | 451M | 100.0% | +150.7% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 451M | +146.7% | −66.0M | -14.6% | -1.59 | −22.3M |
| FY2024 | 183M | +948.6% | −116M | -63.4% | -3.07 | −84.6M |
| FY2023 | 17.4M | -32.4% | −136M | -779.5% | -4.62 | −119M |
| FY2022 | 25.8M | -54.7% | −62.1M | -240.5% | -2.52 | −49.5M |
| FY2021 | 57.0M | – | −13.8M | -24.2% | -0.67 | 3.2M |
| FY2020 | 0.00 | – | −26.8M | –% | -4.32 | −21.6M |
| FY2019 | – | – | −4.7M | –% | -1.98 | −3.8M |
| FY2018 | – | – | −1.3M | –% | – | – |